Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Involvement of Systemic Lymphoma”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07812493
What this trial is testing

Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

Who this might be right for
PirtobrutinibImmunochemotherapyDLBCL - Diffuse Large B Cell Lymphoma+1 more
Pengpeng Xu 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06901999
What this trial is testing

Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

Who this might be right for
CNS Lymphoma
Ruijin Hospital 23
Early research (Phase 1)Active Not RecruitingNCT05211336
What this trial is testing

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System

Who this might be right for
Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
National Cancer Institute (NCI) 14
Not applicableStudy completedNCT01319591
What this trial is testing

Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate

Who this might be right for
CNS LymphomaCNS Involvement of Systemic Lymphoma
Dana-Farber Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00553943
What this trial is testing

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma
Lymphoma Study Association 60
Testing effectiveness (Phase 2)Study completedNCT02329080
What this trial is testing

New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

Who this might be right for
Diffuse Large B-cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 79